Prohibition Partners

Prohibition Partners · Free weekly briefing

International Cannabis Weekly

The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.

73

7 regions29 stories21 countries

← №72All issues№74 →

Europe

8 stories
  • Coalition parties in Luxembourg confirm plans to legalise recreational cannabis

    LUAdult-uselink no longer available

  • Aurora completes its first medical cannabis shipment to the Czech Republic

    CZMedicallink no longer available

  • Wayland Group enters UK medical cannabis market

    GBMedicallink no longer available

  • Greek government plans for medical cannabis exports

    GRMedicallink no longer available

  • Irish mother who paved the way for medical cannabis programme to stand for election

    IEEvents & Industrylink no longer available

  • Denmark issued 1,571 prescription cannabis products in Q2 2018

    DKMedicallink no longer available

  • One in ten French adults consumed cannabis in 2017

    FRAdult-uselink no longer available

  • New policy report urges Ireland to decriminalise drug possession

    IERegulationlink no longer available

United States

2 stories
  • US lawmakers close to passing a bill that would federally legalise industrial hemp

    USRegulationlink no longer available

  • Massachusetts dispensaries sell $2.2 million of recreational cannabis in first five days

    USAdult-uselink no longer available

Canada

1 story
  • Health Canada revokes Ascent Industries' federal cannabis licences

    CARegulationlink no longer available

LATAM & Caribbean

7 stories
  • Antigua and Barbuda set to legalise cannabis for religious and medical purposes

    AGRegulationlink no longer available

  • Mexico's COFEPRIS approves 38 cannabis products, 21 of which are food supplements

    MXRegulationlink no longer available

  • Key Brazilian Senate committee signs off on medical cannabis bill

    BRMedicallink no longer available

  • ICC Labs opens medical cannabis production site in Uruguay

    UYBusiness & Investmentlink no longer available

  • Khiron to launch CBD cosmetics brand in Peru

    PEHemp & CBDlink no longer available

  • The solution to cannabis' energy problem could be in South America

    Business & Investmentlink no longer available

  • Bermuda will allow domestic medical cannabis cultivation

    BMMedicallink no longer available

Africa & Middle East

1 story
  • Lesotho's costly cannabis cultivation licences are forcing smaller producers underground

    LSRegulationlink no longer available

APAC

3 stories
  • South Korea becomes the first country in East Asia to legalise medical cannabis

    KRMedicallink no longer available

  • Thailand's National Legislature approves the first draft of a medical cannabis bill

    THMedicallink no longer available

  • Indian government scientists announce research into medical cannabis

    INHealth & Sciencelink no longer available

Oceania

4 stories
  • Australian senator introduces a bill to legalise recreational cannabis

    AUAdult-uselink no longer available

  • New Zealand's medical cannabis bill has passed a second reading

    NZMedicallink no longer available

  • Sydney-based THC Global to import medical cannabis products to New Zealand

    NZMedicallink no longer available

  • CannTrust ships CBD oil capsules to Australian university hospital for clinical trials

    AUHealth & Sciencelink no longer available

Health & Science

  • Ancient viruses contributed to the evolution of hemp and cannabis

    Health & Sciencelink no longer available

  • University of BC commences study on making safe and effective cannabis drinks

    CAHealth & Sciencelink no longer available

  • Improved cannabis access needs to be considered by medical surgeons

    Medicallink no longer available

Never miss an issue

International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.

From the research library

Global Medical Cannabis Market Review

14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.

From £1,265

View report